Tetsuji Asao

1.7k total citations
65 papers, 1.4k citations indexed

About

Tetsuji Asao is a scholar working on Molecular Biology, Organic Chemistry and Pharmaceutical Science. According to data from OpenAlex, Tetsuji Asao has authored 65 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 36 papers in Organic Chemistry and 7 papers in Pharmaceutical Science. Recurrent topics in Tetsuji Asao's work include Synthesis and Characterization of Heterocyclic Compounds (22 papers), Synthesis and biological activity (11 papers) and Chemical Synthesis and Analysis (9 papers). Tetsuji Asao is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (22 papers), Synthesis and biological activity (11 papers) and Chemical Synthesis and Analysis (9 papers). Tetsuji Asao collaborates with scholars based in Japan, United States and India. Tetsuji Asao's co-authors include Yukio Tada, Kosaku Hirota, Yuji Yamada, Konstanty Wierzba, Norihiko Suzuki, Shingo Yano, Masakazu Fukushima, Tomohiro Emura, Hideki Kazuno and Shigeo Senda and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Immunology and Clinical Cancer Research.

In The Last Decade

Tetsuji Asao

58 papers receiving 1.3k citations

Peers

Countries citing papers authored by Tetsuji Asao

Since Specialization

Citations

This map shows the geographic impact of Tetsuji Asao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuji Asao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuji Asao more than expected).

Fields of papers citing papers by Tetsuji Asao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuji Asao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuji Asao. The network helps show where Tetsuji Asao may publish in the future.

Co-authorship network of co-authors of Tetsuji Asao

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuji Asao. A scholar is included among the top collaborators of Tetsuji Asao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuji Asao. Tetsuji Asao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DNA interstrand crosslinking agents: Synthesis, DNA interactions, and cytotoxicity of dimeric achiral seco-amino-CBI and conjugates of achiral seco-amino-CBI with pyrrolobenzodiazepine (PBD) 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Atsushi Sato, (unknown), (unknown), (unknown), Stephen J. Hudson, C. Caroline O’Hare, Konstantinos Kiakos, Tetsuji Asao, Moses Lee, John A. Hartley	14
2	TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect. 2005 ·PubMed ·Yasuji Yamamoto, Jiro Shibata, Kazuhiko Yonekura, (unknown), Akihiro Hashimoto, Yoshimi Aoyagi, Konstanty Wierzba, Shingo Yano, Tetsuji Asao, Aman U. Buzdar, (unknown)	29
3	Synthesis and Structure‐Activity Relationship of 4‐Substituted Benzoic Acids and their Inhibitory Effect on the Biosynthesis of Fatty Acids and Sterols 2005 ·Archiv der Pharmazie ·(unknown), Kazuo Ogawa, Shingo Yano, Masakazu Fukushima, Norihiko Suzuki, Tetsuji Asao	5
4	Napthalimidobenzamide DB-51630: a novel DNA binding agent inducing p300 gene expression and exerting a potent anti-cancer activity 2005 ·Bioorganic & Medicinal Chemistry ·Kenji Suzuki, Hideko Nagasawa, Yoshihiro Uto, Yoshikazu Sugimoto, Keiichi Noguchi, (unknown), Konstanty Wierzba, (unknown), Tetsuji Asao, Yuji Yamada, Kenji Kitazato, Hitoshi Hori	31
5	The Anticancer Natural Product Pironetin Selectively Targets Lys352 of α-Tubulin 2004 ·Chemistry & Biology ·Takeo Usui, Hiroyuki Watanabe, Hiroshi Nakayama, Yukio Tada, Naoki Kanoh, Masuo Kondoh, Tetsuji Asao, Koji Takio, Hidenori Watanabe, Kiyohiro Nishikawa, Takeshi Kitahara, Hiroyuki Osada	90
6	Suppression of Pathogenicity of Porphyromonas gingivalis by Newly Developed Gingipain Inhibitors 2004 ·Molecular Pharmacology ·Tomoko Kadowaki, (unknown), Naoko Abe, Ryosuke Takii, (unknown), Takayuki Tsukuba, (unknown), (unknown), Tetsuji Asao, Kenji Yamamoto	97
7	Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 2: Optimization of inhibitors of human thymidine phosphorylase and their selectivity with uridine phosphorylase 2004 ·Bioorganic & Medicinal Chemistry ·Shingo Yano, Hideki Kazuno, Tsutomu Sato, Norihiko Suzuki, Tomohiro Emura, Konstanty Wierzba, Jun‐ichi Yamashita, Yukio Tada, Yuji Yamada, Masakazu Fukushima, Tetsuji Asao	48
8	Cooperative Action of Arg- and Lys-gingipains in Disruption of Fibronectin-Integrin Interactions in Human Gingival Fibroblasts 2002 ·(unknown), Tomoko Kadowaki, Tetsuji Asao, Kenji Yamamoto	1
9	Self-association and unique DNA binding properties of the anti-cancer agent TAS-103, a dual inhibitor of topoisomerases I and II 2002 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Keisuke Ishida, Tetsuji Asao	28
10	Treatment with cathepsin L inhibitor potentiates Th2-type immune response in Leishmania major-infected BALB/c mice 2001 ·International Immunology ·Tianqian Zhang, Yoichi Maekawa, Tohru Sakai, Yoko Nakano, Kazunari Ishii, Hajime Hisaeda, Teruki Dainichi, Tetsuji Asao, Nobuhiko Katunuma, Kunisuke Himeno	26
11	Splenic Cathepsin L Is Maturated from the Proform by Interferon-γ after Immunization with Exogenous Antigens 2001 ·Biochemical and Biophysical Research Communications ·Tianqian Zhang, Yoichi Maekawa, Tohru Sakai, Yoko Nakano, Kazunari Ishii, Hajime Hisaeda, Eiki Kominami, Nobuhiko Katunuma, Tetsuji Asao, Kunisuke Himeno	9
12	Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2′-deoxyribonucleosides 2000 ·Biochemical Pharmacology ·Masakazu Fukushima, Norihiko Suzuki, Tomohiro Emura, Shingo Yano, Hideki Kazuno, Yukio Tada, (unknown), Tetsuji Asao	198
13	Pepstatin A-Sensitive Aspartic Proteases in Lysosome Are Involved in Degradation of the Invariant Chain and Antigen-Processing in Antigen Presenting Cells of Mice Infected with Leishmania major 2000 ·Biochemical and Biophysical Research Communications ·Tianqian Zhang, Yoichi Maekawa, Koji Yasutomo, Hiroyuki Ishikawa, Baher Nashed, Teruki Dainichi, Hajime Hisaeda, Tohru Sakai, (unknown), Toshiaki Mizuochi, Tetsuji Asao, Nobuhiko Katunuma, Kunisuke Himeno	21
14	Inhibition Mechanism of Cathepsin L-Specific Inhibitors Based on the Crystal Structure of Papain–CLIK148 Complex 1999 ·Biochemical and Biophysical Research Communications ·Hideaki Tsuge, Tomohiro Nishimura, Yukio Tada, Tetsuji Asao, Vito Türk, Nobuhiko Katunuma	87
15	Switch of CD4+ T Cell Differentiation from Th2 to Th1 by Treatment with Cathepsin B Inhibitor in Experimental Leishmaniasis 1998 ·The Journal of Immunology ·Yoichi Maekawa, Kunisuke Himeno, Hiroyuki Ishikawa, Hajime Hisaeda, Tohru Sakai, Teruki Dainichi, Tetsuji Asao, Robert A. Good, Nobuhiko Katunuma	79
16	TAS-301, an Inhibitor of Smooth Muscle Cell Migration and Proliferation, Inhibits Intimal Thickening after Balloon Injury to Rat Carotid Arteries 1998 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Yasundo Yamasaki, Yoshihisa Nozawa, (unknown), (unknown), N. ODA, Atsushi Satoh, Tetsuji Asao, Hidekazu Miyake, Naosuke Matsuura	13
17	Interaction of DP-TAT-59, an active metabolite of new triphenylethylene-derivative (TAT-59), with estrogen receptors 1992 ·The Journal of Steroid Biochemistry and Molecular Biology ·(unknown), Kenichi Matsuo, Jiro Shibata, (unknown), Mamoru Nukatsuka, Setsuo Takeda, Yuji Yamada, Tetsuji Asao, Takahisa Hirose, Bunzo Sato	6
18	TAT-59, a new triphenylethylene derivative with antitumor activity against hormone-dependent tumors 1990 ·European Journal of Cancer and Clinical Oncology ·(unknown), Yoshikazu Sugimoto, (unknown), (unknown), Setsuo Takeda, Konstanty Wierzba, Tetsuji Asao, Yuji Yamada	31
19	New photochemical synthesis of 6-alkylamino-5-amino-1,3-dimethyluracils from 6-azido-1,3-dimethyluracil and amines 1976 ·Journal of the Chemical Society Chemical Communications ·Shigeo Senda, Kosaku Hirota, Mikio Suzuki, Tetsuji Asao, (unknown)	3
20	Reaction of 5-Nitrouracil Derivatives with Hydrazine and Potassium Cyanide 1976 ·Heterocycles ·Shigeo Senda, Kosaku Hirota, Tetsuji Asao, Yoshihiro Yamada	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact